Bicoll Biotechnology (Shanghai) Co. Ltd. completes modernization of its laboratory facilities for medicinal chemistry
Bicoll Biotechnology (Shanghai) Co. Ltd., announced that it has completed the modernization of its laboratory facilities for medicinal chemistry within Zhangjiang Hi-Tech Park, Shanghai to meet increasing demand for its medicinal chemistry capacities. At its central laboratory facility in Shanghai, Bicoll provides pre-clinical support in the area of drug discovery from natural products and medicinal chemistry.
“With the now completed remodernization we stay abreast of a continuously increasing demand for high-quality medicinal chemistry and custom synthesis. Validating hits and optimizing leads into drug candidates often represents the bottleneck of drug development programs, especially if it comes to natural product like chemistry. Today’s challenge consists of shortening the optimization process, improving quality of compound flow and project management, thus reducing overall costs. As a specialist in pre-clinical support we already expanded to nearly double the size of lab space in 2005. For Bicoll it’s a matter of course to serve its partners best and continue to deliver products in time, budget and quality,” commented Dr. Christian Haug, Chairman of Board of Directors at Bicoll Biotechnology (Shanghai) Co. Ltd.
Other news from the department manufacturing
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
